Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
21.5M
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
14.7M
-
Shares change
-
+648K
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$59M
-
Put/Call ratio
-
0.34
-
Number of buys
-
105
-
Number of sells
-
-63
-
Price
-
$80.91
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) as of Q1 2018
195 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock as of Q1 2018.
ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.7M shares
of 21.5M outstanding shares and own 68.31% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.36M shares), FARALLON CAPITAL MANAGEMENT LLC (915K shares), FIRST MANHATTAN CO (872K shares), VANGUARD GROUP INC (866K shares), RENAISSANCE TECHNOLOGIES LLC (845K shares), STATE STREET CORP (758K shares), Krensavage Asset Management, LLC (740K shares), DIMENSIONAL FUND ADVISORS LP (593K shares), JANUS HENDERSON GROUP PLC (494K shares), and Invesco Ltd. (473K shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.